Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
Although physician consent requirements are widespread across Europe, the fact is that different EU member countries have different rules surrounding the issue. Out of all, around 14 countries have a law or code in place, five countries (including France, Portugal, Romania, Netherlands, and Denmark) do not require consent, five countries (including Greece, Austria, Luxembourg, Hungary […]
Law enforcement authorities have indicted executives and physicians affiliated with the physician-owned Forest Park Medical Center for allegedly paying or accepting bribes and kickbacks in exchange for referring patients to the hospital. According to an announcement released by the Department of Justice, top-level executives and doctors affiliated with the hospital had established shell companies and […]
Pharma companies made $7.15 billion worth of ‘transfers of value’ in 2015 to physicians and hospitals. With all that wealth of industry data made publicly available through the Federal Open Payments program, the Department of Justice (DoJ) and federal and state prosecutors have sprung into action to investigate fraud across the healthcare system. This treasure […]
Gaining physician consent for data disclosure purposes under the EFPIA disclosure code is never easy. However, considering that the acquisition of consent is part of the law under the Directive 95/46/EC on the protection of individuals with regard to the processing of personal data, this is something pharma companies in the EU cannot overlook. With HCP’s […]
The 3rd Annual Global Compliance Congress for Life Sciences was held by the CBI at the Hilton London Olympia on the 16th & 17th of November, 2016. The conference provided an excellent platform for representatives of life sciences companies to network, share ideas and learn from one another. The ambiance at the conference was high-energy […]
For most pharma companies in the EU, seeking the consent of the HCP’s/HCO’s that they indulge in transactions is the most appropriate means of ensuring compliance with data protection laws when disclosing their spending under the EFPIA disclosure code. Indeed, the Code comes with guidance notes that place special emphasis on pharmaceutical companies seeking consent […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use